Oracle introduced Oracle Life Sciences AI Agents on November 18, 2026, making an AI-assisted coordination layer for clinical trial operations available to early adopters. The agents initially focus on portfolio monitoring, trial planning, and trial conduct, with proposed actions subject to human review and approval. The agents bring together insights from Oracle Life Sciences applications and supported third-party data sources. They are designed to identify operational issues, recommend…
Read the original article:
Oracle Introduces AI Agents to Coordinate Clinical Trial Operations
